Patents by Inventor Pamela De Moor

Pamela De Moor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROTEIN SOLUTION FORMULATION CONTAINING HIGH CONCENTRATION OF AN ANTI-VEGF ANTIBODY
    Publication number: 20240182554
    Abstract: The present invention provides anti-VEGF antibodies formulated as high concentration, aqueous pharmaceutical compositions, suitable for an injection, preferably an intravitreal injection. The aqueous pharmaceutical compositions are useful for delivery of a high concentration of the antibody active ingredient to a patient without high levels of antibody aggregation and without a high level of sub-visible particulate matter. An aqueous composition of the invention comprises an antibody having a concentration of at least 50 mg/ml. An aqueous pharmaceutical composition of the invention includes a sugar, a buffering agent, and a surfactant.
    Type: Application
    Filed: February 16, 2024
    Publication date: June 6, 2024
    Inventors: Pamela DE MOOR, Juergen SIGG
  • Protein solution formulation containing high concentration of an anti-VEGF antibody
    Patent number: 11945859
    Abstract: The present invention provides anti-VEGF antibodies formulated as high concentration, aqueous pharmaceutical compositions, suitable for an injection, preferably an intravitreal injection. The aqueous pharmaceutical compositions are useful for delivery of a high concentration of the antibody active ingredient to a patient without high levels of antibody aggregation and without a high level of sub-visible particulate matter. An aqueous composition of the invention comprises an antibody having a concentration of at least 50 mg/ml. An aqueous pharmaceutical composition of the invention includes a sugar, a buffering agent, and a surfactant.
    Type: Grant
    Filed: December 16, 2019
    Date of Patent: April 2, 2024
    Assignee: NOVARTIS AG
    Inventors: Juergen Sigg, Pamela De Moor
  • PROTEIN SOLUTION FORMULATION CONTAINING HIGH CONCENTRATION OF AN ANTI-VEGF ANTIBODY
    Publication number: 20200190179
    Abstract: The present invention provides anti-VEGF antibodies formulated as high concentration, aqueous pharmaceutical compositions, suitable for an injection, preferably an intravitreal injection. The aqueous pharmaceutical compositions are useful for delivery of a high concentration of the antibody active ingredient to a patient without high levels of antibody aggregation and without a high level of sub-visible particulate matter. An aqueous composition of the invention comprises an antibody having a concentration of at least 50 mg/ml. An aqueous pharmaceutical composition of the invention includes a sugar, a buffering agent, and a surfactant.
    Type: Application
    Filed: December 16, 2019
    Publication date: June 18, 2020
    Inventors: Juergen Sigg, Pamela De Moor
  • Packing respiring biological materials with atmosphere control member
    Patent number: 6013293
    Abstract: Packaging of fruit and vegetables, and other respiring biological materials, makes use of an atmosphere-control member comprising a gas-permeable membrane and an apertured cover member over the membrane. The combination results in a control member having a ratio of CO.sub.2 transmission rate to O.sub.2 transmission rate which is lower than the same ratio for the gas-permeable membrane. This is particularly useful for materials which are preferably stored in an atmosphere containing a relatively high proportion of CO.sub.2.
    Type: Grant
    Filed: September 10, 1997
    Date of Patent: January 11, 2000
    Assignee: Landec Corporation
    Inventor: Colette Pamela De Moor